GENEURO SA
9Patents
9Active
9Granted
43Portfolio score
Filing activity: Jul 8, 2009 → Jun 17, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8715656B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 3 | Active |
| US9550824B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 2 | Active |
| US9815888B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 2 | Active |
| US10723787B2 | Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody | Physics | 1 | Active |
| US9840550B2 | Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein | Chemistry; Metallurgy | 0 | Active |
| US10752675B2 | Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein | Chemistry; Metallurgy | 0 | Active |
| US10059758B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 0 | Active |
| US10981977B2 | Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis | Physics | 0 | Active |
| US10894820B2 | Antiretroviral drug targeting human endogenous retrovirus | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.